Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis

Conclusions: We used EXOs as a carrier for intraocular delivery of KV11. We showed that KV11 itself has an anti-angiogenic effect through retro-orbital injection, but that this effect was greatly enhanced when delivered with EXOs. Thus, this system has the potential to treat proliferative retinopathy via retro-orbital injection which is a less invasive manner compared with intravitreal injection.
Source: Theranostics - Category: Molecular Biology Authors: Tags: Research Paper Source Type: research